Arrowhead Research | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Arrowhead Research USD 21.65M 7M 2024-12
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
Ligand Pharmaceuticals USD 883K 142K 2024-12
Merck USD 313M 15M 2025-03
Moderna USD 1000K 5M 2025-03
Novartis USD 275M 11M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
TG Therapeutics USD 10.83M 6.86M 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Xencor -39359000 40.15M 2024-12



Arrowhead Research Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.